The ABCA3 gene helps lung cells make surfactant, the slippery material that keeps the tiny air sacs in the lungs open so breathing is easier. The protein made by this gene helps your cells package fats needed for surfactant. If ABCA3 does not work well, babies may have major breathing problems soon after birth, and some children or adults develop ongoing lung disease. Pathogenic variants in both copies of the ABCA3 gene can confirm ABCA3 related surfactant dysfunction.
What is a gene?
Genes are stretches of DNA that give your cells instructions to make molecules or guide processes in the body. Some genes hold the information needed to produce proteins, which do much of the cell’s work. Other genes are used mainly to regulate when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ABCA3Gene function
What if the gene works
The ABCA3 gene helps lung cells package fats into surfactant, the slippery material that coats the air sacs. This supports easy breathing by helping the air sacs stay open after each breath.
Risk
What if the gene does not work
Variants in the ABCA3 gene can disrupt surfactant handling in the lungs. Milder variants may cause childhood interstitial lung disease, while more severe variants often lead to breathing problems from birth and can vary in timing and severity.
Treatment
What does that mean for your treatment
No ABCA3 specific treatment or drug choice is currently established in clinical guidelines for pathogenic variants in the ABCA3 gene. The gene is being studied in early research as a target for treatments that might improve surfactant processing in the lungs.
Conditions associated with ABCA3
Gene function
What if the gene works
With each breath, your lungs rely on surfactant, a slippery material that helps the tiny air sacs open and close smoothly. A key part of what the ABCA3 gene does in the lungs is help special lung cells prepare this material. That support helps breathing stay efficient from the first breaths of life onward.
Inside special lung cells, the ABCA3 gene moves certain fats into small storage sacs that hold surfactant. This supplies key ingredients for the lung coating that lines the air sacs.
Its protein helps organize surfactant inside lamellar bodies (small storage packets in lung cells). This neat packing helps the material stay ready for release onto the air sac surface.
By helping make lung surfactant, the ABCA3 gene supports a lining that lowers surface tension (the pull that can make air sacs tighten). That helps the tiny air sacs open more easily with each breath.
What is a variant?
A genetic variant is a small change in a gene’s DNA sequence. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ABCA3 gene can leave the protein misshapen, unstable, trapped inside the cell, or less able to move fats into surfactant storage sacs. Some changes have a partial effect, while more disruptive variants can leave little or no working protein. This helps explain why ABCA3 gene variants and lung disease can vary, with two severe variants more often linked to symptoms at birth and milder combinations sometimes appearing later.
How variants are linked to conditions
Pathogenic variants in the ABCA3 gene can cause newborn breathing problems and childhood interstitial lung disease. When disease-causing variants are present in both copies of the gene, they can lead to severe respiratory distress soon after birth or to a longer-term diffuse lung condition that appears in infancy, childhood, or sometimes later. The course can vary widely, even among people in the same family.
A variant is not necessarily a diagnosis
Genetic variants are common in the general population and are a normal feature of human biology. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ABCA3, personal risk is mainly shaped by the gene changes inherited from both parents, and severe lung disease usually happens when a child has harmful changes in both copies of the ABCA3 gene. There is not yet broadly confirmed evidence that specific lifestyle or environmental factors clearly increase or lower ABCA3-related risk.
Inheritance of ABCA3 variants
ABCA3-related lung conditions are usually inherited in an autosomal recessive pattern. This means a child inherits two disease-causing variants in the ABCA3 gene, typically one from each parent. Parents who each carry one ABCA3 gene variant usually do not have the condition themselves, but with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant. This is the usual pattern doctors mean when explaining how ABCA3 gene variants are inherited.
What does my ABCA3 result mean for my family?
For ABCA3, family members are usually affected only when a child inherits a changed copy from each parent. This means parents are often healthy carriers, and brothers and sisters may also be affected or may be carriers. Other close relatives, such as adult siblings of the parents, may also carry an ABCA3 change in the family.
Genetic information
Genetic testing
How you find out about variants
ABCA3 genetic testing uses a blood, saliva, or cheek swab sample to look for variants in the ABCA3 gene. A lab reads the gene's DNA sequence and may also check for missing pieces. Results can show whether no variant, one variant, or two variants were found, which helps clarify whether ABCA3 is involved.
When should I consider getting a genetic test?
Consider genetic testing for ABCA3 if a newborn has severe breathing trouble without a clear cause, or if a child has ongoing unexplained lung disease. Testing can also help when ABCA3-related lung disease is known in the family, or when more than one baby in the family has had similar serious breathing problems.
A genetic result is only one part of your health story
Genetic findings can be informative, but how much they explain varies by the condition and the kind of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get the expected benefit while another may have less effect or be more sensitive to side effects. This happens in part because inherited differences can change how the body absorbs, breaks down, transports, or responds to a drug. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect a person’s response to medicines. By studying gene drug relationships, it helps explain why the same treatment may not work the same way for everyone. For many drugs, genes influence both how the body handles the medicine and how strong its effects may be. This information can support treatment choices that are more informed and more tailored to the individual. More detail on this topic is available in the LearnHub.
Drugs influenced by the ABCA3 gene
When should I seek medical advice?
There isn’t yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects someone may have. Questions about breathing symptoms, lung care, or concerns about any medicine are best discussed with your doctor.
History
The ABCA3 gene entered medical genetics in the early 2000s, when researchers studying newborns and children with unexplained severe lung disease found changes in this gene. Initially understood only through visible traits, later recognized as tied to a specific gene, these findings helped explain some cases of surfactant deficiency that had previously been hard to classify. From these first observations, research expanded steadily, linking ABCA3 variants not only to breathing failure in infancy but also to longer-term childhood lung disease. Over time, descriptions became more precise as genetic testing and lung tissue studies clarified the range of ABCA3-related illness. This history helped turn a puzzling group of rare lung conditions into a more clearly defined inherited condition.